NC
BHC icon

Nicholas Company’s Bausch Health BHC Stock Holding History

Nicholas Company’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,633,000
Closed -$42.9M – 202
2016
Q1 		$42.9M Buy
1,633,000
+46,075
+3% +$3.41M 0.87% 35
2015
Q4 		$161M Buy
1,586,925
+214,435
+16% +$24.1M 3.02% 3
2015
Q3 		$245M Sell
1,372,490
-23,410
-2% -$5.46M 4.64% 1
2015
Q2 		$310M Buy
1,395,900
+41,445
+3% +$9.19M 5.42% 1
2015
Q1 		$269M Sell
1,354,455
-515
-0% -$91.4K 5.07% 1
2014
Q4 		$194M Buy
1,354,970
+26,750
+2% +$3.6M 3.97% 1
2014
Q3 		$174M Hold
1,328,220
– – 4.1% 1
2014
Q2 		$168M Sell
1,328,220
-184,310
-12% -$23.5M 3.98% 2
2014
Q1 		$199M Buy
1,512,530
+16,200
+1% +$2.22M 4.81% 1
2013
Q4 		$176M Buy
1,496,330
+20,020
+1% +$2.19M 4.27% 1
2013
Q3 		$154M Buy
1,476,310
+70,985
+5% +$6.92M 4.12% 1
2013
Q2 		$121M Buy
+1,405,325
New +$111M 3.7% 1

Other funds holding BHC

PSCM
Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nicholas Company's BHC Position: Q2 2016 in Review

Nicholas Company sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 1,633,000 shares — an estimated $42.9M sold.

Nicholas Company first reported a position in BHC in Q2 2013 and held it in 12 quarters. The position peaked at $310M in Q2 2015. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

  • Nicholas Company reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
  • Nicholas Company sold 1,633,000 Bausch Health shares in Q2 2016, an estimated $42.9M.
  • Nicholas Company first reported a position in Bausch Health in Q2 2013 and held it in 12 quarters.
  • Nicholas Company's Bausch Health position peaked at $310M in Q2 2015.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Nicholas Company's 13F filing for Q2 2016, filed 12 Aug 2016.